Anti-GD2 antibody therapy alters the neuroblastoma tumor microenvironment and extends survival in TH-MYCN mice

MLA

Spyridon A. Karageorgos, et al. Anti-GD2 Antibody Therapy Alters the Neuroblastoma Tumor Microenvironment and Extends Survival in TH-MYCN Mice. June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a049180138b845312c34a4ab632bd2e6&authtype=sso&custid=ns315887.

APA

Spyridon A. Karageorgos, Hogarty, Hamid Bassiri, Kevin O McNerney, Ferry G, Vemu R, Chakkapong Burudpakdee, Adam J. Wolpaw, Priya Khurana, & Annette Vu. (2021). Anti-GD2 antibody therapy alters the neuroblastoma tumor microenvironment and extends survival in TH-MYCN mice.

Chicago

Spyridon A. Karageorgos, Hogarty, Hamid Bassiri, Kevin O McNerney, Ferry G, Vemu R, Chakkapong Burudpakdee, Adam J. Wolpaw, Priya Khurana, and Annette Vu. 2021. “Anti-GD2 Antibody Therapy Alters the Neuroblastoma Tumor Microenvironment and Extends Survival in TH-MYCN Mice,” June. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a049180138b845312c34a4ab632bd2e6&authtype=sso&custid=ns315887.